BIM
ANIP icon

BlackRock Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

BlackRock Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.54M Buy
41,857
+7,219
+21% +$441K ﹤0.01% 2061
2016
Q3 		$2.3M Buy
34,638
+1,164
+3% +$72.8K ﹤0.01% 2045
2016
Q2 		$1.87M Buy
33,474
+1,798
+6% +$87.4K ﹤0.01% 2159
2016
Q1 		$1.07M Buy
31,676
+102
+0.3% +$3.46K ﹤0.01% 2442
2015
Q4 		$1.43M Buy
31,574
+414
+1% +$17.8K ﹤0.01% 2325
2015
Q3 		$1.23M Sell
31,160
-517
-2% -$29.4K ﹤0.01% 2448
2015
Q2 		$1.97M Buy
31,677
+7,138
+29% +$425K ﹤0.01% 2249
2015
Q1 		$1.53M Buy
24,539
+4,891
+25% +$298K ﹤0.01% 2217
2014
Q4 		$1.11M Sell
19,648
-353
-2% -$15.6K ﹤0.01% 2481
2014
Q3 		$566K Buy
20,001
+234
+1% +$7.01K ﹤0.01% 2902
2014
Q2 		$681K Buy
+19,767
New +$620K ﹤0.01% 2864

Other funds holding ANIP

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

BlackRock Investment Management's ANIP Position: Q4 2016 in Review

BlackRock Investment Management increased its ANI Pharmaceuticals (ANIP) stake by 21% in Q4 2016, buying an estimated $441K and bringing the position to 41,857 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

BlackRock Investment Management first reported a position in ANIP in Q2 2014 and has held it in 11 quarters since. 157 funds tracked by Wall St. Rank hold ANIP as of Q4 2016.

  • BlackRock Investment Management held 41,857 shares of ANI Pharmaceuticals worth $2.54M as of Q4 2016.
  • BlackRock Investment Management bought 7,219 ANI Pharmaceuticals shares in Q4 2016, an estimated $441K.
  • ANI Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2061 holding.
  • BlackRock Investment Management first reported a position in ANI Pharmaceuticals in Q2 2014 and has held it in 11 quarters since.
  • 157 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.